117 related articles for article (PubMed ID: 9419417)
1. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.
Irby R; Mao W; Coppola D; Jove R; Gamero A; Cuthbertson D; Fujita DJ; Yeatman TJ
Cell Growth Differ; 1997 Dec; 8(12):1287-95. PubMed ID: 9419417
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential.
Mao W; Irby R; Coppola D; Fu L; Wloch M; Turner J; Yu H; Garcia R; Jove R; Yeatman TJ
Oncogene; 1997 Dec; 15(25):3083-90. PubMed ID: 9444956
[TBL] [Abstract][Full Text] [Related]
3. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
4. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
5. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
Marchetti D; Parikh N; Sudol M; Gallick GE
Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
[TBL] [Abstract][Full Text] [Related]
7. Activating SRC mutation in a subset of advanced human colon cancers.
Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
[TBL] [Abstract][Full Text] [Related]
8. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.
Guan RJ; Ford HL; Fu Y; Li Y; Shaw LM; Pardee AB
Cancer Res; 2000 Feb; 60(3):749-55. PubMed ID: 10676663
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
Fujimoto E; Sato H; Shirai S; Nagashima Y; Virgona N; Hagiwara K; Yamasaki H; Negishi E; Ueno K; Yano T
Oncol Rep; 2006 May; 15(5):1359-65. PubMed ID: 16596211
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
[TBL] [Abstract][Full Text] [Related]
11. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
[TBL] [Abstract][Full Text] [Related]
12. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon A; Gold LI; Wang J; Cohen A; Friedman E
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
[TBL] [Abstract][Full Text] [Related]
13. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
[TBL] [Abstract][Full Text] [Related]
14. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells.
Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
Br J Cancer; 1999 Apr; 79(11-12):1651-6. PubMed ID: 10206273
[TBL] [Abstract][Full Text] [Related]
16. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.
Mamidipudi V; Dhillon NK; Parman T; Miller LD; Lee KC; Cartwright CA
Oncogene; 2007 May; 26(20):2914-24. PubMed ID: 17072338
[TBL] [Abstract][Full Text] [Related]
17. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
[TBL] [Abstract][Full Text] [Related]
18. Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells.
Alessandro R; Flugy AM; Russo D; Stassi G; De Leo A; Corrado C; Alaimo G; De Leo G
J Cell Physiol; 2005 Apr; 203(1):261-72. PubMed ID: 15484219
[TBL] [Abstract][Full Text] [Related]
19. Molecular and biological properties of hamster tumor cell lines transformed with B77 virus: expression of v-src does not correlate with metastatic potential.
Kisseleva NP; Sabová L; Weismanová E
Neoplasma; 1991; 38(3):293-301. PubMed ID: 1713304
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
